SCHEMBL342676

SCHEMBL342676

CC1(CO)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31303847 1.00 EPHX1 (0.53) —
Ammonia Solution, Strong SCHEMBL2286653 0.96 — —
Alcohol SCHEMBL3149030 0.93 — —
SCHEMBL26117100 0.93 — —
Lithium Ion SCHEMBL26117105 0.90 — —
SCHEMBL16094027 0.90 EPHX1 (0.46) —
SCHEMBL16359606 0.90 EPHX1 (0.46) —
SCHEMBL19601348 0.87 EPHX1 (0.43) —
SCHEMBL1930892 0.86 — —
SCHEMBL17427 0.86 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1158 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3523366-B1 METHOD FOR RECYCLING POLYOLEFIN CONTAINING WASTE FRAUNHOFER GES FORSCHUNG (DE) 2025-08-06 — — EP claimed
EP-4511463-A2 PERFUME CONCRETE AND ABSOLUTE WHICH ARE OBTAINED BY ORGANIC (POLY)OL SOLVENT EXTRACTION FROM SOLID NATURAL SUBSTANCES L'OREAL (FR) 2025-02-26 — — EP claimed
EP-3752499-B1 INHIBITORS OF TRPC6 BOEHRINGER INGELHEIM INT (DE) 2024-03-27 — — EP claimed
WO-2023203098-A2 PERFUME CONCRETE AND ABSOLUTE WHICH ARE OBTAINED BY ORGANIC (POLY)OL SOLVENT EXTRACTION FROM SOLID NATURAL SUBSTANCES L'OREAL (FR) 2023-10-26 — — WO claimed
US-11673883-B2 Heterocyclic compounds as immunomodulators INCYTE CORPORATION (US) 2023-06-13 — — US claimed
US-20230174457-A1 INSECT REPELLENT COMPOUNDS AND COMPOSITIONS, AND METHODS THEREOF UNIV IOWA STATE RES FOUND INC (US) 2023-06-08 — — US claimed
CN-109689647-B Bicyclic heteroaryl substituted compounds 百时美施贵宝公司 2023-01-20 — — CN claimed
EP-3464279-B1 HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS INCYTE CORP (US) 2021-11-24 — — EP claimed
US-10934410-B2 Method for recycling polyolefin containing waste Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) 2021-03-02 — — US claimed
US-20200399282-A1 INHIBITORS OF TRPC6 BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2020-12-24 — — US claimed
EP-1880720-B1 SUBSTITUTED ACRYLAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DAIICHI SANKYO CO LTD (JP) 2013-02-13 — — EP claimed
US-20120220593-A1 Substituted Acrylamide Derivative and Pharmaceutical Composition Comprising the Same DAIICHI SANKYO COMPANY, LIMITED (JP) 2012-08-30 — — US claimed
US-8084645-B2 4-phenylamino-benzaldoxime derivatives and uses thereof as mitogen-activated protein kinase kinase (MEK) inhibitors CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2011-12-27 — — US claimed
US-20090118199-A1 SUBSTITUTED ACRYLAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DAIICHI SANKYO COMPANY , LIMITED (JP) 2009-05-07 — — US claimed
EP-1880720-A1 SUBSTITUTED ACRYLAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME Daiichi Sankyo Company, Limited (JP) 2008-01-23 — — EP claimed
US-20070105859-A1 4-Phenylamino-benzaldoxime derivatives and uses thereof as mitogen-activated protein kinase kinase (mek) inhibitors CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2007-05-10 — — US claimed
EP-1674452-A1 NOVEL 4-PHENYLAMINO-BENZALDOXIME DERIVATIVE AND USE THEREOF AS MEK INHIBITOR CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2006-06-28 — — EP claimed
US-6989052-B1 Phase change ink printing process XEROX CORPORATION (US) 2006-01-24 — — US claimed
US-20060004123-A1 PHASE CHANGE INK PRINTING PROCESS XEROX CORPORATION 2006-01-05 — — US claimed
US-5569664-A AGRICULTURAL INSECTICIDES FMC CORPORATION (US) 1996-10-29 — — US claimed
Send feedback